Clinical Trial: Biodistribution, Dosimetry, and Safety of 68Ga-EV203 in Hematological Malignancies

U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07670949) titled 'Biodistribution, Dosimetry, and Safety of 68Ga-EV203 in Hematological Malignancies' on June 18.

Brief Summary: The goal of this clinical trial is to evaluate the biodistribution, radiation dosimetry, safety, and time-dependent image quality of ^68^Ga-EV203 injection in patients with hematological malignancies (multiple myeloma, non-Hodgkin lymphoma, or acute myeloid leukaemia), aged 18-75 years, who are able to lie still for 0.5 h and have no contraindications (e.g., pregnancy, recent radiotherapy, etc.).

The main questions it aims to answer are:

What are the biodistribution (organ uptake, %ID, SUV) and radiation absorbed doses (m...